top of page
A new approach to de-risk your development and commercialisation journey, taking advantage of your data
In 2021, 30% of studies reviewed for FDA approval received a Complete Response Letter
Causal Analysis is an emerging technique used in several industries already, and is recognised by the FDA
Causal AI appears on Gartner’s 2022 Hype Cycle for Emerging Technologies
incubate.bio has built a computational platform called ALaSCA to rapidly apply Causal Discovery and Causal Inference with biological data and RWD
Antimicrobial Resistance Case Study
Common causal questions asked
Contact us for more info: raminderpal@incubate.bio
bottom of page